SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in DSGN — Design Therapeutics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in DSGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$226,455
-$353,716 QoQ
Shares Held
15,650
-74.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 136 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Derivatives in DSGN
reported options exposure · as of Jun 30, 2026CallValue
$578,800
CallShares
40,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. DSGN ranks #223 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
1,053,896 | $140,442,180 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,549,458 | $131,998,327 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
180,219 | $112,373,755 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
294,460 | $88,641,293 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148,610 | $79,796,139 | |
| 6 | INSM |
INSMED Inc
|
729,354 | $77,763,723 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
144,174 | $71,615,550 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,375,558 | $51,046,957 |
All Filings in DSGN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,455 | 15,650 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $578,800 | 40,000 | Call | Other | 2026-08-14 | |
| 2025-12-31 | $580,171 | 61,852 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $105,593 | 14,023 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $43,810 | 13,000 | Call | Other | 2025-08-14 | |
| 2025-06-30 | $128,632 | 38,170 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $166,840 | 43,223 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $230,215 | 37,312 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $74,244 | 13,800 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $47,905 | 14,300 | Put | Defined | 2024-08-15 | |
| 2024-06-30 | $72,782 | 21,726 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $45,264 | 11,232 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $242,210 | 91,400 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $316,940 | 119,600 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $55,374 | 20,896 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $289,336 | 122,600 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $53,187 | 22,537 | Shares | Defined | 2023-11-14 | |
| 2023-09-30 | $236,236 | 100,100 | Call | Defined | 2023-11-14 | |
| 2023-06-30 | $357,801 | 56,794 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,754,478 | 304,069 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $1,886,814 | 183,900 | Call | Defined | 2023-02-14 | |
| 2022-12-31 | $250,918 | 24,456 | Shares | Defined | 2023-02-14 | |
| 2022-12-31 | $152,874 | 14,900 | Put | Defined | 2023-02-14 | |
| 2022-09-30 | $306,243 | 18,316 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $312,664 | 18,700 | Put | Defined | 2022-11-14 | |
| 2022-09-30 | $2,668,512 | 159,600 | Call | Defined | 2022-11-14 | |
| 2022-06-30 | $827,400 | 59,100 | Call | Defined | 2022-08-15 | |
| 2022-06-30 | $334,656 | 23,904 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||